One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1053/S0272-6386(21)00739-3
Volume 78, Issue 3, September 2021, Pages A5-A8
The Empty Chair
NicoleScholes-Robertson
doi : 10.1053/j.ajkd.2021.03.015
Volume 78, Issue 3, September 2021, Page A11
New-Onset Proteinuria in a Patient With Schwannoma
LiannAbu Salman1ChristosKallis2MatthewPalmer3JehanBahrainwala1Abdallah S.Geara1
doi : 10.1053/j.ajkd.2021.03.031
Volume 78, Issue 3, September 2021, Pages A12-A15
A Roadmap for Innovation to Advance Transplant Access and Outcomes: A Position Statement From the National Kidney Foundation
Krista L.Lentine1StephenPastan2SumitMohan3Peter P.Reese6AlanLeichtman7Francis L.Delmonico8Gabriel M.Danovitch9Christian P.Larsen14LyndsayHarshman10AlexanderWiseman11Holly J.Kramer12JosephVassalotti45JessicaJoseph4KevinLongino4MatthewCooper13?David A.Axelrod15?
doi : 10.1053/j.ajkd.2021.05.007
Volume 78, Issue 3, September 2021, Pages 319-332
Using GFR, Albuminuria, and Their Changes in Clinical Trials and Clinical Care
JosefCoresh12Morgan E.Grams12Teresa K.Chen2
doi : 10.1053/j.ajkd.2021.04.003
Volume 78, Issue 3, September 2021, Pages 333-334
Tubular Kidney Biomarker Insights Through Factor Analysis
Carl P.Walther1Julia S.Benoit2
doi : 10.1053/j.ajkd.2021.03.016
Volume 78, Issue 3, September 2021, Pages 335-337
Recurrent Arteriovenous Hemodialysis Access Procedures: The Hidden Details
Adrian P.AbreoBakhtiar M.AminKenneth D.Abreo
doi : 10.1053/j.ajkd.2021.03.013
Volume 78, Issue 3, September 2021, Pages 338-339
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
Lesley A.Inker1Hiddo J.L.Heerspink3HocineTighiouart24JuhiChaudhari1ShiyuanMiao1UlyssesDiva5AlexMercer6Gerald B.Appel7James V.Donadio8JürgenFloege9Philip K.T.Li10Bart D.Maes11FrancescoLocatelli12ManuelPraga14Francesco P.Schena13Andrew S.Levey1TomGreene15
doi : 10.1053/j.ajkd.2021.03.007
Volume 78, Issue 3, September 2021, Pages 340-349.e1
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression
Brendon L.Neuen1MisghinaWeldegiorgis12William G.Herrington3ToshiakiOhkuma16MargaretSmith45MarkWoodward127
doi : 10.1053/j.ajkd.2021.02.335
Volume 78, Issue 3, September 2021, Pages 350-360.e1
Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants
Alexander L.Bullen1RonitKatz4VasanthaJotwani57Pranav S.Garimella2Alexandra K.Lee5Michelle M.Estrella57Michael G.Shlipak567?Joachim H.Ix123?
doi : 10.1053/j.ajkd.2021.01.021
Volume 78, Issue 3, September 2021, Pages 361-368.e1
Arteriovenous Vascular Access–Related Procedural Burden Among Incident Hemodialysis Patients in the United States
Kenneth J.Woodside12Kaitlyn J.Repeck5PurnaMukhopadhyay5Douglas E.Schaubel16Vahakn B.Shahinian13RajivSaran134Ronald L.Pisoni5
doi : 10.1053/j.ajkd.2021.01.019
Volume 78, Issue 3, September 2021, Pages 369-379.e1
Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network Registry
SophiePloos van Amstel1MarliesNoordzij1DagmaraBorzych-Duzalka23Nicholas C.Chesnaye1HongXu4LesleyRees5Il-SooHa6Zenaida L.Antonio7NakysaHooman8WilliamWong9KarelVondrak10Yok ChinYap11HirenPatel12MariaSzczepanska13SaraTesta14MonicaGalanti15Jameela A.Kari16CharlotteSamaille17Sevcan A.Bakkaloglu18Wai-MingLai19Luisa FernandaRojas20Mabel SandovalDiaz21BiswanathBasu22AliciaNeu23Bradley A.Warady24Kitty J.Jager1FranzSchaefer2
doi : 10.1053/j.ajkd.2020.11.031
Volume 78, Issue 3, September 2021, Pages 380-390
Association of Physical Activity and Poor Health Outcomes in Patients With Advanced CKD
ChristieRampersad1RanveerBrar2KelseyConnelly1PaulKomenda12ClaudioRigatto12BhanuPrasad2ClaraBohm12NavdeepTangri12
doi : 10.1053/j.ajkd.2020.12.018
Volume 78, Issue 3, September 2021, Pages 391-398
Catheter Dependence After Arteriovenous Fistula or Graft Placement Among Elderly Patients on Hemodialysis
BeiniLyu1Micah R.Chan2Alexander S.Yevzlin3Brad C.Astor12
doi : 10.1053/j.ajkd.2020.12.019
Volume 78, Issue 3, September 2021, Pages 399-408.e1
Risk of Symptomatic Kidney Stones During and After Pregnancy
CharatThongprayoon1Lisa E.Vaughan2ApiChewcharat1Andrea G.Kattah1Felicity T.Enders2RajivKumar1John C.Lieske1Vernon M.Pais4Vesna D.Garovic13Andrew D.Rule1
doi : 10.1053/j.ajkd.2021.01.008
Volume 78, Issue 3, September 2021, Pages 409-417
Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review
AleksandraKukla1?PedroVentura-Aguiar2?MatthewCooper3Eelco J.P.de Koning4David J.Goodman5Paul R.Johnson6Duck J.Han7Didier A.Mandelbrot8MarthaPavlakis9FrantisekSaudek10Marie-ChristineVantyghem11TitusAugustine12Michael R.Rickels13
doi : 10.1053/j.ajkd.2021.02.339
Volume 78, Issue 3, September 2021, Pages 418-428
IgA Nephropathy: Core Curriculum 2021
PrapaPattrapornpisut123CarmenAvila-Casado24Heather N.Reich125
doi : 10.1053/j.ajkd.2021.01.024
Volume 78, Issue 3, September 2021, Pages 429-441
Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021
Sheryl F.Vondracek13IsaacTeitelbaum23Tyree H.Kiser13
doi : 10.1053/j.ajkd.2021.02.342
Volume 78, Issue 3, September 2021, Pages 442-458
Proliferative Glomerulonephritis With Fibrils, Monoclonal ? Light Chain, and C3 Deposits
Adam G.Steinberg1Lucy C.Fox4SebastienBender5AhidaBatrouney2SurenderJuneja3ChristopheSirac5GuyTouchard6PiersBlombery4Moira J.Finlay27FrankBridoux56Thomas D.Barbour17
doi : 10.1053/j.ajkd.2021.01.014
Volume 78, Issue 3, September 2021, Pages 459-463
A Practical Guide to Interpret Individual Participant Data Meta-analysis of Observational Studies
Shoshana H.Ballew?YejinMok?KunihiroMatsushita
doi : 10.1053/j.ajkd.2021.02.333
Volume 78, Issue 3, September 2021, Pages 464-467
Verinurad/Febuxostat and Nephrotoxicity
RaulFernandez-PradoMDAlbertoOrtizMD, PhD
doi : 10.1053/j.ajkd.2021.03.029
Volume 78, Issue 3, September 2021, Page 468
In Reply to ‘Verinurad/Febuxostat and Nephrotoxicity’
Austin G.StackMD1FredrikErlandssonMD, PhD2RobertTerkeltaubMD3
doi : 10.1053/j.ajkd.2021.05.009
Volume 78, Issue 3, September 2021, Pages 468-469
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
HirotakaKomabaMD, PhD12TakehikoWadaMD, PhD1MasafumiFukagawaMD, PhD1
doi : 10.1053/j.ajkd.2021.05.006
Volume 78, Issue 3, September 2021, Pages 469-470
Association of Baclofen With Falls and Fractures in Patients With CKD
Flory T.MuandaMD, PhD12Peter G.BlakeMB, FRCPC3Matthew A.WeirMD, MSc123LavanyaBathiniMD13KiannaChauvinBSc3Stephanie N.DixonPhD12EricMcArthurMSc1Jessica M.SontropPhD23LouiseMoistMD, MSc23Richard B.KimMD, FRCPC4Amit X.GargMD, PhD123
doi : 10.1053/j.ajkd.2020.12.017
Volume 78, Issue 3, September 2021, Pages 470-473
